Evidence map›Paper›PMID 41498069›Full record

ArticleFrontiers in plant science2025

A lightweight intelligent grading method for lychee anthracnose based on improved YOLOv12.

Bing Xu, Zejie Ma, Xueping Su, Xiaoru He, Xianjun Wu

Abstract read
In one paragraph

Article in Frontiers in plant science, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Bing XuSchool of Computer, Guangdong University of Petrochemical Technology, Maoming, Guangdong, China.
Zejie MaSchool of Computer, Guangdong University of Petrochemical Technology, Maoming, Guangdong, China.
Xueping SuSchool of Computer, Guangdong University of Petrochemical Technology, Maoming, Guangdong, China.
Xiaoru HeSchool of Computer, Guangdong University of Petrochemical Technology, Maoming, Guangdong, China.
Xianjun WuSchool of Computer, Guangdong University of Petrochemical Technology, Maoming, Guangdong, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Anthracnose is one of the primary diseases leading to quality deterioration in lychee. Traditional manual grading methods suffer from low efficiency and high subjectivity. To achieve rapid, non-destructive detection and intelligent grading of lychee anthracnose, while addressing the challenge of balancing high accuracy and lightweight design in detection models, this study proposes a lightweight improved model named LycheeGuard-Lite based on the YOLOv12 framework. By introducing the C3k2_Light module reconstructed with depthwise separable convolutions, a dual-path C2PSA attention mechanism (position-channel dual-path attention), and the wConv2D weighted convolution strategy, the model enhances lesion feature extraction capability while reducing computational complexity.Evaluation was performed on a self-built dataset comprising 14, 576 images of two dominant lychee varieties ('Feizixiao' and 'Baitangying') collected under multiple lighting conditions and annotated with three severity levels (Mild, Moderate, Severe). The results demonstrate that the model maintains 99.4% mAP50 detection accuracy while reducing its number of parameters to 2.19M (a 12.8% decrease) and computational cost to 4.1 GFLOPs (a 29.3% reduction).This research provides a lightweight and deployable algorithmic foundation for automated lychee disease recognition and intelligent grading, offering practical engineering value for post-harvest fruit sorting and quality management.

Indexed as

attention mechanismdisease classificationlightweight modellychee anthracnoseYOLOv12

Identifiers

PMID41498069
PMCPMC12766746

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.